Eric Turtle

Company: Lycia Therapeutics

Job title: Director - Chemistry

Seminars:

Ligand Design for LYTAC Extracellular Protein Degradation 3:30 pm

Learn how Lysosomal Targeting Chimeras (LYTACs) offer a new opportunity to target classes of secreted proteins which have been challenging for existing therapeutic inhibitors Unveil small molecule linker-ligands designed for optimal receptor binding, bioconjugation, and stability of conjugates has enabled new applications using small molecule-protein based LYTACs Design and properties of LYTACs to maximize efficiency of…Read more

day: Conference Day One